SNT 25.7% 4.4¢ syntara limited

Phase one trial results of the NASH drug they have already...

  1. 252 Posts.
    Phase one trial results of the NASH drug they have already sold/partnered with big pharma (due third quarter, so expect before end of September) and full recruitment of the U.S. Phase 3 trial (also with a partner)
 
watchlist Created with Sketch. Add SNT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.